Haifaa Abdulhaq MD

Hematologic Oncology

Physician

785 Medical Center Drive West203Fresno, CA 93611
Phone+1 559-387-1900
Fax+1 559-387-1950

Dr. Abdulhaq is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abdulhaq's full profile Already have an account?

Education & Training

Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2005 - 2008
Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2002 - 2005
Damascus University Faculty of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2010 - 2028
PA State Medical License 2002 - 2010
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.
Jeremy S Abramson, William Townsend, Christopher P Fox, Matthew Ku, Mark Hertzberg
Blood Advances. 2026-08-11
What to know about rare B-cell malignancies in 2025.
Salman Fazal, Yazan Samhouri, Cyrus Khan, Haifaa Abdulhaq
Hematology. American Society of Hematology. Education Program. 2025-12-05
Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report.
Sundeep Bekal, Haifaa Abdulhaq
Cureus. 2025-05-01

Press Mentions

Central Valley Hospitals Join Elite Group Offering Revolutionary CAR-T Cancer TherapyNovember 18th, 2025
$New Two-Year Follow-up of Roche’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma Patients$
New Two-Year Follow-up of Roche’s Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma PatientsMay 22nd, 2025